Fidelity SPDR Advertisement
Home > Boards > US OTC > Biotechs >

PuraMed BioScience, Inc. (PMBS)

PMBS RSS Feed
Add PMBS Price Alert      Hide Sticky   Hide Intro
Moderator: No Moderator mick, Tadaaa, rs99, stockchaser64, MoneyStocksID2014, Meach2
Search This Board:
Last Post: 8/21/2014 12:13:23 AM - Followers: 351 - Board type: Free - Posts Today: 1






PuraMed BioScience, Inc. is a U.S. SEC Registered & Reporting Company
http://www.otcmarkets.com/stock/pmbs/quote

Symbol: PMBS

https://www.puramedbioscience.com/

http://www.lipigesic.com/



Share Structure:
 As Of July 24th, 2014  1.4 Billion Shares as Float (O/S)

As Of July 24th, 2014  4 Billion Shares Authorized (A/S)

40/1 Reverse Split in the Process which per company filings will result in Approximately 37 Million Shares Outstanding and Meet the OTCQB requirements.





 

About the Company

PuraMed was established to capture two unique opportunities. The first is to build a substantial and profitable business, rapidly, beginning with three products developed by its founders: LipiGesic® M (for acute relief of migraine headaches), LipiGesic® H(for acute relief of tension headaches) and PuraMed™ PM (for insomnia). Each of these is effective and addresses a very large OTC consumer market, collectively well over $2 billion in the U.S. Each product will be unique in its class.

The second, longer term, opportunity is to establish a leadership position in the highly fragmented OTC natural and alternative health remedy market by introducing a “new kind of product line.” Our product line will consist of ‘alternative’ remedies for common ailments, marketed to the masses. Most consumers want products that are, first of all, effective and safe. By applying hard science to ‘natural’ products, management believes it is possible to build a line wherein each product delivers better performance with fewer side effects than its chemical counterparts. With effective marketing, these products will be embraced by the majority, many of whom prefer ‘natural’ alternatives, provided there is no need to sacrifice performance or convenience.

PuraMed BioScience has completed a double blind placebo clinical trial for its leading product, LipiGesic® M, a sublingual acute treatment for the relief from migraine headaches, which was published in the top-tier medical journal, Headache. http://onlinelibrary.wiley.com/doi/10.1111/j.1526-4610.2011.01910.x/abstract 
LipiGesic® M has national distribution and is available nationwide in some of the largest chain drug stores in the United States.


CLICK HERE to Read Lipigesic Clinical Trial 2011 Study

 

Products

Feverfew 3X, the main active ingredient in LipiGesic® M (for migraine relief), is an herb that has been recognized for centuries as having a beneficial effect on migraine, menstrual and other headaches. Another active ingredient, Ginger 2X, is anti-inflammatory, specifically suppressing the expression of several mediators felt crucial in migraine pathogenesis.
Read more: http://www.puramedbioscience.com/lipigesic-m/


 

A combination of acetylsalicylic acid (aspirin) and St. John’s Wort delivered utilizing our sublingual gel delivery system can dramatically increase the speed and levels of relief for many tension headache sufferers.
Read more: http://www.puramedbioscience.com/lipigesic-h/

 


 

Valerian, St. John’s Wort and Chamomile, all ingredients in LipiGesic® PM (for insomnia), have each been clinically demonstrated to promote healthy sleep. 
Read more: http://www.puramedbioscience.com/lipigesic-pm/

 




Where to Buy

LipiGesic M is will be available in CVS and Walgreens pharmacy stores!

New Distributors to be Announced soon!!!

 

 
 

Click Here to Buy Online:

 
 
http://www.calciumsupreme.com/lipigesic

PMBS product are also in stock and available thru the following retailers as of 07/30/2014-also this is not a complete list:
Healthy Grade Supplements 
AeroComp 
Ezpickin 
Itzadeal 
C&KShoppe 
Dynamic Marketing Concepts USA 
Amaday in Paradise 
December Sun Market 
C-C Warehouse


Recent News

   

PuraMed BioScience Develops a Cannabis-based Epilepsy Medication

 

SCHOFIELD, Wis., Aug. 5, 2014 /PRNewswire/ -- PuraMed BioScience®, Inc., (OTCPink: PMBS), a researcher, developer, and marketer of over-the-counter (OTC) medicinal and healthcare products, announced today that it plans to begin testing of a new hemp-based epilepsy medication in the fourth quarter of 2014.

"As we looked at the similarities between migraine and epilepsy the treatment path became obvious," saidRussell Mitchell, CEO and Chairman of PuraMed BioScience. "Epilepsy and migraine seem to be triggered by the same coritcal spreading depression (CSD) in the brain; the difference is the rate of reaction. This may be why many migraineurs are prescribed epileptic medications."

According to an article in Seizure, the prevalence of migraine in people who experience epilepsy is 8.4 to 20 percent. In addition to migraine, an estimated 64 percent of epilepsy sufferers also experience seizure-related (ictal) headaches: 20 percent experience headache prior to the seizure (pre-ictal) and 44 percent experience headache after the seizure (post-ictal).

The third most common neurological disorder in the US, epilepsy affects approximately 2.7 million people, with children and older adults being most susceptible. The condition also causes up to 50,000 sudden deaths each year.

Epilepsy affects veterans wounded in combat. According to Citizens United to Cure Epilepsy, approximately 22 percent of the 440,000 military service men and women who experienced traumatic brain injury are expected to develop post-traumatic epilepsy.

"An epilepsy medication is a natural extension to our product line," said Mitchell. "We have developed a formula, now we will begin the setting up the trials. We have been approached by key researchers who have expressed interest in working with us on CBD-based products.

"Standardization is key to creating a quality sublingual formula," said Mitchell. " Sublingual delivery offers the distinct advantages of faster delivery and efficiency while avoiding the "first pass effect" that often degrades oral medications. Our goal is to build medicines that withstand scientific scrutiny and perform well in double-blind, placebo controlled clinical trials. We believe that the efficacy of our formulations will be proven by scientific trials. This type of testing lends credibility to our line of natural medications which often work faster, more effectively, and have fewer side effects than their chemical-based counterparts."

Currently, PuraMed BioScience is rebranding its flagship product, LipiGesic M, as MigraPure.

About MigraPure

MigraPure uses the same sublingual feverfew and ginger formula that was clinically tested as LipiGesic M. The flavor of this homeopathic, all-natural, over-the-counter migraine headache pain relief medication has been enhanced, but the active ingredients that stop disabling migraine pain and associated symptoms quickly, is the same. MigraPure's feverfew and ginger gel is non-drowsy and non-habit forming. MigraPure is not associated with rebound headaches. MigraPure has an excellent safety profile and has no reported drug interactions. 

About PuraMed BioScience, Inc.

PuraMed BioScience engages in the research, development, and marketing of non-prescription medicinal and healthcare products. In addition to rebranding LipiGesic M to MigraPure, PuraMed BioScience plans to launch additional cannabinoid-enhanced, anti-inflammatory, and anxiolytic products as it moves forward in the development of its cannabinoid product line.

Forward-Looking Statements

This news release contains forward-looking statements regarding PuraMed BioScience, Inc., and its future business plans, which statements involve known and unknown risks and uncertainties. Such risks and uncertainties may cause actual results and future achievements of PuraMed BioScience to be materially different from those implied by these forward-looking statements. PuraMed BioScience has and undertakes no obligation to provide public updates and revisions to these forward-looking statements to reflect any changes in its expectations of future events.

Contact: 
PuraMed BioScience, Inc.
Russell Mitchell, Chairman and CEO 
715-359-6373
rmitchell@PuramedBioScience.com 
www.PuramedBioScience.com

PuraMed BioScience Rebrands its Natural Migraine Relief Medication, LipiGesic M

 

SCHOFIELD, Wis., July 30, 2014 /PRNewswire/ -- PuraMed BioScience®, Inc., (OTCPink:PMBS), a researcher, developer, and marketer of over-the-counter (OTC) medicinal and healthcare products, announced today that the company is rebranding the LipiGesic® M name along with the name's red and yellow logo. The former will be replaced with the trademarked name MigraPure®  going forward. The new name, logo, and color palette of PuraMed's homeopathic, natural migraine pain reliever will be reintroduced into selected segments of the retail marketplace.

"We've been working on this for over a year," saidRussell Mitchell, CEO and Chairman of PuraMed BioScience. "We needed to secure the trademark for the name and create the image before we announced the development of the enhanced formula and our product line extensions. 

"The new name will be easier for people to remember and pronounce," said Mitchell. "We also believe the new look and color of the logo will convey our 'safe' and 'natural' message at a glance. Preliminary feedback about the change has been positive and we are pleased. We will now have packaging that reflects the excellent product inside."

PuraMed hopes to have the new product, which uses a flavor-enhanced version of the sublingual LipiGesic M formula, new packaging, new price point, and a new website ready for public purchase within the next two months, though promotion and distribution to retailers and targeted wholesale partners will begin earlier.

"The manufacturing order has been placed," said Mitchell. "Our marketing plan is being finalized and as soon as the packaging and the website are ready, we will launch."

MigraPure's fresh look and message will replace the red and yellow LipiGesic logo. A tagline that describes the product will also be a fundamental part of the logo.

"By using a tagline with the image, we can make a stronger statement and leave no doubt in the consumer's mind about what MigraPure is or what it does, which is also an improvement," said Mitchell. "During the re-launch, we will also reference LipiGesic M on the packaging and other marketing materials in order to maintain a connection with our clinical trial data and our current customer base."

Development of the gel, packaging, and launch of the website are the first steps in the rebranding effort. PuraMed plans to continue to sell LipiGesic M under the old label until the new product is available.

A version of the new logo can be seen at www.lipigesic.com/MigraPure.

About MigraPure

MigraPure uses the same sublingual feverfew and ginger formula that was clinically tested as LipiGesic M. The flavor of this all-natural, over-the-counter migraine headache pain relief medication has been enhanced, but the active ingredients that stop disabling migraine pain and associated symptoms quickly, are the same. MigraPure's feverfew and ginger gel is non-drowsy and non-habit forming. MigraPure is not associated with rebound headaches. MigraPure has an excellent safety profile and has no reported drug interactions. 

About PuraMed BioScience, Inc.

PuraMed BioScience engages in the research, development, and marketing of non-prescription medicinal and healthcare products. In addition to rebranding LipiGesic M to MigraPure, PuraMed BioScience plans to launch additional cannabinoid-enhanced, anti-inflammatory, and anxiolytic products as it moves forward in the development of its cannabinoid product line.

Forward-Looking Statements

This news release contains forward-looking statements regarding PuraMed BioScience, Inc., and its future business plans, which statements involve known and unknown risks and uncertainties. Such risks and uncertainties may cause actual results and future achievements of PuraMed BioScience to be materially different from those implied by these forward-looking statements. PuraMed BioScience has and undertakes no obligation to provide public updates and revisions to these forward-looking statements to reflect any changes in its expectations of future events.

Contact:
PuraMed BioScience, Inc.
Russell Mitchell, Chairman and CEO
715-359-6373
rmitchell@PuramedBioScience.com
www.PuramedBioScience.com

SOURCE PuraMed BioScience, Inc.

Current LipiGesic M videos

  Dr. Cady videoDr. Roger Cady, discusses the results of treatment of migraine headache with fever few and ginger, the active ingredients in the migraine treatment LipiGesic® M.
VIEW NOW
  Sherry TorkosPharmacist Sherry Torkos recommends all-natural, homeopathic LipiGesic® M.
VIEW NOW
  Nutrition and J.J. Virgin fitness expert J.J. Virgin shares how LipiGesic® M has helped her teenage son eliminate migraine pain.
VIEW NOW

 

 


 

 



      REBRANDING, TRADEMEARK AND PATENTS ARE NOW COMPLETE 07/30/2014      


 

  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
PMBS
Current Price
Volume:
Bid Ask Day's Range
Wiki
PMBS News: PuraMed BioScience Partners with Operation Troop Aid to Sponsor Care Packages 07/22/2014 08:49:00 AM
PMBS News: PuraMed BioScience Announces Product Donation at a Sponsorship Level to Operation Gratitude 07/08/2014 09:11:00 AM
PMBS News: PuraMed BioScience and Honoring Our Troops Partner Together to Sponsor a PTSD Event 06/11/2014 08:00:00 AM
PMBS News: PuraMed BioScience moves forward with the development of its first cannabinoid-based medicine 04/09/2014 07:25:00 PM
PostSubject
#17728  Sticky Note ~Key Elements of Recent Filings~ MoneyStocksID2014 07/30/14 08:41:31 AM
#16148  Sticky Note 07-11-14/ Report Filing (8-k) Puramed Bioscience, Inc. (PC) mick 07/11/14 09:01:50 PM
#10811  Sticky Note THIS PR IS GETTING NATION WIDE COVERAGE!..THIS IS vans 04/10/14 01:32:15 AM
#18967   As a post-mortem... Can anyone explain why Russ released vseeker 08/21/14 12:13:23 AM
#18966   So no bid? Been out the last couple rs99 08/20/14 09:38:26 PM
#18965   So i take it we hit no bid rs99 08/20/14 09:34:34 PM
#18964   you are WAY off on the outstanding shares, Gharet 08/20/14 04:52:44 PM
#18963   Doesn't really matter who counts them, the outcome Gharet 08/20/14 04:50:41 PM
#18962   Just because YOU don't "know who's selling", does HHHG 08/20/14 03:35:28 PM
#18961   Selling in the bid usually dilution!! Who knows Abismanto 08/20/14 03:22:56 PM
#18960   You are new at this arent you??? Das88 08/20/14 02:40:40 PM
#18959   Who's Counting the shareholder votes Friday ? inplay 08/20/14 02:39:00 PM
#18958   I'm confused, how can a stock even sell xaq 08/20/14 02:37:38 PM
#18957   Well no one knows who's selling. And were brando5 08/20/14 01:53:24 PM
#18956   aaaaand ZERO lol ZviTrader 08/20/14 01:26:19 PM
#18955   How we looking today guys?? We rocket to Gharet 08/20/14 01:04:36 PM
#18954   Any one know how much the outstanding share Abismanto 08/19/14 09:25:09 PM
#18953   Then why the massive ATM dilution like today? skyrocketinsight 08/19/14 06:56:47 PM
#18952   From what I see happening and the name brando5 08/19/14 06:44:56 PM
#18950   The reason for the number 40 is they Gharet 08/19/14 04:32:15 PM
#18949   500+ million in volume today LOL!!!! The Gharet 08/19/14 04:29:26 PM
#18948   Clever TheWatcher51 08/19/14 03:56:05 PM
#18947   PM BS Had to be done. stratford1 08/19/14 03:55:13 PM
#18946   Disgusting.... TheWatcher51 08/19/14 03:41:02 PM
#18945   ZERO BID!!! WE talked about it, and hence HHHG 08/19/14 02:43:10 PM
#18944   Yeah, 0 bid now, slapping that ask at .0001. wodehouse 08/19/14 02:19:44 PM
#18943   This company is finished, they will dilute after Gharet 08/19/14 01:36:33 PM
#18942   PMBS doesn't look healthy:( Snizzle 08/19/14 12:57:47 PM
#18940   Agreed, but who's buying? I know I'm not. Rocco63 08/19/14 12:34:55 PM
#18939   Yep, and there is no question this is HHHG 08/19/14 12:21:13 PM
#18938   I sure it you let the R/S go guessrightlol 08/19/14 12:12:48 PM
#18937   MASSIVE DUMP! Gharet 08/19/14 12:09:37 PM
#18936   but why now? this R/S has been announced xaq 08/19/14 12:09:32 PM
#18935   No bid, unless one has 5th digit trading Tadaaa 08/19/14 12:04:52 PM
#18934   People trying to exit as fast as they Rocco63 08/19/14 12:04:14 PM
#18933   wow what did I just wake up to? xaq 08/19/14 12:00:03 PM
#18932   If I'm correct, their is a R/S in guessrightlol 08/19/14 11:56:40 AM
#18931   No bid? LaorgeMONEY 08/19/14 11:53:18 AM
#18930   Why the tremendous dump $PMBS LaorgeMONEY 08/19/14 11:47:46 AM
#18929   Looking dreamy now! ammoking 08/19/14 11:34:05 AM
#18928   Too many companies use excuse words like if, skyrocketinsight 08/19/14 09:42:56 AM
#18927   Won't be long that were over a penny brando5 08/19/14 02:37:54 AM
#18926   I hope everyone voted no on split. Every brando5 08/19/14 02:33:03 AM
#18925   Number of shares goes down value of shares brando5 08/19/14 02:31:53 AM
#18924   Lol ha brando5 08/19/14 02:31:12 AM
#18923   1s won't be obtainable of company moves forward brando5 08/19/14 02:30:04 AM
#18922   JMO but I think .0001's will be very skyrocketinsight 08/18/14 09:52:46 PM
#18921   $PMBS: Mongol: LMAO! Best Post of the day....... :>) ChartTRACKER 08/18/14 06:18:09 PM
#18920   You might run out of your daily posts Mongol76 08/18/14 05:19:07 PM
#18919   1-40 R/S 40,000 shares go down to 1,000 shares inplay 08/18/14 04:36:54 PM
#18918   Your math could use some help; it's actually Rocco63 08/18/14 04:30:40 PM
#18917   The BIG R/S vote is friday August 22 inplay 08/18/14 04:23:11 PM
#18916   R/S 10,000 shares goes down to 250 shares inplay 08/18/14 04:21:04 PM
PostSubject